<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.05 Limitations. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.09/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.09/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|09|03|.05|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|09|03|.05" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.09.03.05"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".05 Limitations. | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09" title="Subtitle 09 MEDICAL CARE PROGRAMS">Subtitle 09 MEDICAL CARE PROGRAMS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09.03" title="Chapter 03 Pharmacy Services">Chapter 03 Pharmacy Services</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03|.05" data-search-heading="">
                  <span title=".05 Limitations.">.05 Limitations.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|09|03|.05">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.09.03.05">.05 Limitations.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> Except as specifically identified as being covered under <a class="internal-link " href="/us/md/exec/comar/10.09.03.04" title=".04 Covered Services.">Regulation .04 of this chapter</a>, the following are not covered:</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> Nonlegend drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> Medical supplies and durable equipment;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> Any original prescription for a controlled substance dispensed more than 30 days after the date it was ordered;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(4)">(4)</span> Drugs supplied to hospital inpatients;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(5)">(5)</span> Drugs and supplies dispensed by the provider with an actual acquisition cost of $0;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(6)">(6)</span> Experimental or investigational drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(7)">(7)</span> Except where authorized by the Department to be covered under this Regulation, injectables dispensed by a provider for administration by the prescriber;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(8)">(8)</span> Food supplements or infant formulas, including supplemental vitamin and mineral products when administered orally;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(9)">(9)</span> Sugar or salt substitutes;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(10)">(10)</span> Cosmetics, medicine chest supplies, and sundries including all soaps, all body powders, all body oils or body lotions, cotton balls, adhesive strip bandages, cotton-tipped applicators, suntan products, deodorants, dentifrices, tissues, convenience packages of covered items, hot water bottles, ice caps, heating pads, soft cervical collars;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(11)">(11)</span> Alcoholic beverages;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(12)">(12)</span> Ostomy supplies;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(13)">(13)</span> Those services authorized for payment to a prescriber, hospital, nursing facility, hospital outpatient department, or freestanding clinic;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(14)">(14)</span> Oral drugs or injections for central nervous system stimulants, anorexigenics, and any other agents when used for weight control;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(15)">(15)</span> Drug products for which federal financial participation is prohibited pursuant to 42 CFR §441.25;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(16)">(16)</span> Ovulation stimulants unless used to treat an iatrogenic infertility;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(17)">(17)</span> Effective January 1, 2006, any Part D drug for individuals who are eligible for Medicare Part D benefits;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(18)">(18)</span> Drugs or products used for hair growth or other cosmetic purposes;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(19)">(19)</span> Any drug or supply that is covered and reimbursed by the Department under any other chapter of this subtitle; and</p>
                <p class="text-indent-2 "><span class="level-num" id="A(20)">(20)</span> Any drug or product the Department determines is not medically necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> Prescriptions requiring preauthorization according to <a class="internal-link " href="/us/md/exec/comar/10.09.03.06" title=".06 Preauthorization Requirements.">Regulation .06 of this chapter</a> are not covered unless the required preauthorization has been obtained from the Department or its designee.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> Limitations on Covered Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(1)">(1)</span> The allowable cost of ingredients dispensed pursuant to a prescription may not exceed an upper limit as established in Regulation .07, of this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(2)">(2)</span> Refills.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(a)">(a)</span> The prescriber shall authorize refills only on the original prescription if the prescriber determines a refill is necessary and appropriate.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(b)">(b)</span> The Program may authorize no more than 11 refills, not to exceed other applicable federal and State limitations.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(c)">(c)</span> The pharmacy may not automatically refill a prescription unless authorized in writing by the recipient or their designee.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(3)">(3)</span> Days Supply.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(a)">(a)</span> The total amount dispensed under one prescription order, including refills, is limited to a 360 days supply, not to exceed other applicable federal and State limitations.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(b)">(b)</span> Unless otherwise specified, prescriptions shall be limited to a 34 day supply at one time.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(c)">(c)</span> Unless otherwise specified, maintenance medication shall be limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(c)(i)">(i)</span> A 34-day supply for the initial prescription; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(c)(ii)">(ii)</span> Up to a 100-day supply at one time for all subsequent prescriptions.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(d)">(d)</span> Prescriptions shall be dispensed at the lower of the quantity prescribed or the maximum days supply allowed at one time unless:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(d)(i)">(i)</span> The Program authorizes a reduction of the quantity; or</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(d)(ii)">(ii)</span> The prescription is the final refill for the balance remaining on the total prescription order.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(e)">(e)</span> Providers may partially fill a prescription for Schedule II controlled dangerous substances, but the remaining portion of the prescription may not be later filled.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(f)">(f)</span> Oral sodium fluoride products used in the prevention of dental caries are limited to an original prescription of up to a 120-day supply with up to two refills, not to exceed a total of a 360-day supply.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(g)">(g)</span> Prescriptions for drugs packaged by the manufacturer as an unbreakable unit may be dispensed in increments of appropriate package size.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(h)">(h)</span> Whether for an initial or subsequent prescription, contraceptive prescriptions may be dispensed in up to a 12 months supply at one time.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(4)">(4)</span> Generic Drugs.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(a)">(a)</span> Except as limited by §C(4)(b) and (c) of this regulation, when a drug product is prescribed by its nonproprietary or generic name, a provider shall substitute as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(a)(i)">(i)</span> A drug product in the same strength, quantity, dose, and dosage form as the prescribed drug which is, in the provider’s professional opinion, therapeutically equivalent to the drug as prescribed; or</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(a)(ii)">(ii)</span> A drug product with the same generic name in the same strength, quantity, dose, and dosage form as the prescribed drug which is, in the provider’s professional opinion, bioequivalent to the drug as prescribed as rated by the U.S. Food and Drug Administration.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(b)">(b)</span> A provider may not substitute a generic drug for a brand name drug under <a class="internal-link " href="/us/md/exec/comar/10.09.03.05#C(4)(a)" title="">§C(4)(a) of this regulation</a> if:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(b)(i)">(i)</span> The prescriber specifically directs otherwise; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(b)(ii)">(ii)</span> The prescriber requests and received approval from the Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(c)">(c)</span> The Department shall only authorize a provider to substitute a drug product under this regulation when there will be a savings in or no increase in cost to the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(5)">(5)</span> Copayment for Services Rendered on or after July 1, 2005.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(5)(a)">(a)</span> There will be no pharmacy copayment for prescriptions for the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(i)">(i)</span> Individuals younger than 21 years old;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(ii)">(ii)</span> Pregnant women;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(iii)">(iii)</span> Institutionalized individuals who are inpatients in long-term care facilities or other institutions requiring spending all but a minimal amount of income for medical costs;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(iv)">(iv)</span> Family planning drugs and devices; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(v)">(v)</span> Individuals who are American Indians or Alaskan Natives.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(5)(b)">(b)</span> The copayments for prescriptions not excluded from a copayment under <a class="internal-link " href="/us/md/exec/comar/10.09.03.05#C(5)(a)" title="">§C(5)(a) of this regulation</a> are:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(b)(i)">(i)</span> $3 for prescriptions for brand name drugs not on the preferred drug list;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(b)(ii)">(ii)</span> $1 for prescriptions for generic drugs and brand name drugs on the preferred drug list; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(b)(iii)">(iii)</span> $1 for prescriptions for antiretroviral drugs in American Hospital Formulary Service therapeutic class 8:18:08.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(6)">(6)</span> Reimbursement may not be made:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(a)">(a)</span> For nonlegend enteric coated aspirin tablets in strengths other than 300 to 325 milligrams;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(b)">(b)</span> For any other nonlegend aspirin products such as sustained release capsules, buffered tablets, compressed tablets, liquid preparations or combination products in which aspirin is only one of the active ingredients;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(c)">(c)</span> For nonlegend ferrous sulfate products in strengths or dosage forms not listed in <a class="internal-link " href="/us/md/exec/comar/10.09.03.04#A(8)" title="">Regulation .04A(8) of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(d)">(d)</span> For nonlegend iron products combined with other active ingredients, except for chewable tablets as described in <a class="internal-link " href="/us/md/exec/comar/10.09.03.04#A(9)" title="">Regulation .04A(9) of this chapter</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(e)">(e)</span> At a reimbursement level which exceeds the maximum allowable cost established by the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(7)">(7)</span> Condoms dispensed by pharmacy providers are subject to the following limitations:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(a)">(a)</span> The recipient shall present a Medical Assistance card with a current eligibility period;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(b)">(b)</span> Only 12 condoms may be dispensed to an individual at one time;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(c)">(c)</span> The provider may dispense condoms only to the individual named on the Medical Assistance card;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(d)">(d)</span> Natural membrane condoms are not covered; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(e)">(e)</span> Both the recipient receiving the condoms and the provider shall sign the dispensing documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(8)">(8)</span> A compounded prescription for intravenous therapy is subject to the following limitations:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(8)(a)">(a)</span> The Program may not cover a compounded prescription for intravenous therapy if a premixed, therapeutically equivalent commercial intravenous therapy is available from a commercial source;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(8)(b)">(b)</span> The Program may not cover the diluent component of a compounded prescription for intravenous therapy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(8)(c)">(c)</span> All claims submitted require new prescription numbers.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(9)">(9)</span> Prescriptions dispensed to participants residing in nursing facilities are subject to the following limitations:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(9)(a)">(a)</span> Claims shall be identified as nursing facilities prescriptions by coding mechanisms determined by the Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(9)(b)">(b)</span> Credits for unused unit dose medication and any other medication which may legally be returned to pharmacy stock:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(b)(i)">(i)</span> Shall be made within 60 days of Program payment;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(b)(ii)">(ii)</span> May not take into account any professional fee paid by the Program; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(b)(iii)">(iii)</span> Shall adjust for leave of absence prescriptions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(9)(c)">(c)</span> Multiple prescriptions dispensed to a recipient residing in a nursing facility for the same drug product or compounded prescription shall receive only one professional fee per calendar month except for:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(c)(i)">(i)</span> Leave of absence prescriptions;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(c)(ii)">(ii)</span> Prescriptions for intravenous therapy; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(c)(iii)">(iii)</span> Prescriptions for Schedule II-V controlled substances.</p>
                <p class="text-indent-1 "><span class="level-num" id="D">D.</span> Tamper Resistant Prescriptions.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(1)">(1)</span> Prescriptions written on or after April 1, 2008, that do not contain at least one of the tamper-resistant features as defined in Regulation .01B(34)(a) of this chapter are not covered.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(2)">(2)</span> Prescriptions written on or after October 1, 2008, that do not contain all three tamper-resistant features as defined in Regulation .01B(34)(a) of this chapter are not covered.</p>
                <p class="text-indent-1 "><span class="level-num" id="E">E.</span> No covered drug or supply identified under <a class="internal-link " href="/us/md/exec/comar/10.09.03.04" title=".04 Covered Services.">Regulation .04 of this chapter</a> shall be reimbursed under <a class="internal-link " href="/us/md/exec/comar/10.09.03.07" title=".07 Payment Procedures.">Regulation .07 of this chapter</a> if:</p>
                <p class="text-indent-2 "><span class="level-num" id="E(1)">(1)</span> Federal financial participation from the Centers for Medicare &amp; Medicaid Services is not available for the drug or supply; or</p>
                <p class="text-indent-2 "><span class="level-num" id="E(2)">(2)</span> Prior authorization for the drug or supply is required under <a class="internal-link " href="/us/md/exec/comar/10.09.03.06" title=".06 Preauthorization Requirements.">Regulation .06 of this chapter</a> but was not obtained.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.09.03.04" aria-label=".04 Covered Services.">
                <div class="h__ui">Previous</div>
                <span>.04 Covered Services.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.09.03.05-1" aria-label=".05-1 Expanded Limitations.">
                <div class="h__ui">Next</div>
                <span>.05-1 Expanded Limitations.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
